Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

NCT02605486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer (MBC)

Interventions

DRUG: Palbociclib
DRUG: Bicalutamide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]